Bio-Rad Laboratories Inc (BIO):企業のM&A・提携動向(医療分野)

GlobalDataが発行した調査報告書(GDPH648D)
◆英語タイトル:Bio-Rad Laboratories Inc (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH648D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年12月19日
◆ページ数:33
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Bio-Rad Laboratories Inc (Bio-Rad) undertakes the development and manufacture of specialty chemicals for use in biochemical, pharmaceutical and other life science research applications. The company offers a comprehensive range of reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. It offers these products to hospitals, clinical laboratories, universities, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food producers. Through its global network of operations, the company serves more than 100,000 research and healthcare industry customers the world over. The company operates in more than 35 countries in North America, Europe, Asia, Middle East and Africa. Bio-Rad is headquartered in California, the US.

Bio-Rad Laboratories Inc (BIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Bio-Rad Laboratories Inc, Medical Devices Deals, 2010 to YTD 2016 9
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
GnuBio Raises US$10 Million In Series B Financing 12
GnuBio Secures US$5 Million In Second Closing Of Series A Financing 12
Partnerships 13
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 13
AbD Serotec Enters Into Licensing Agreement With Proteomika 13
Genetic Analysis Enters into Agreement with Bio-Rad Labs 14
Bio-Rad Laboratories Enters into Partnership with Illumina 15
AbD Serotec Enters Into Research Agreement With Dana-Farber Cancer Institute 16
Layerlab Enters Into Co-Marketing Agreement With Bio Rad Labs 16
Licensing Agreements 17
Vegenics Enters into Licensing Agreement with Bio-Rad Labs 17
AbD Serotec Amends Licensing Agreement With Merck 18
Serotec Enters Into Licensing Agreement With ICR 19
AbD Serotec Enters Into Licensing Agreement With VU University Medical Center 19
GnuBIO Enters Into Licensing Agreement For Microfluidics And Emulsion Based Methodologies 20
AbD Serotec Enters Into An Agreement With UCL Business 21
Debt Offering 22
Bio-Rad Labs Completes Public Offering Of Senior Notes Due 2020 For US$425 Million 22
Acquisition 23
Bio-Rad Labs Acquires GnuBio, DNA Sequencing Technology Company 23
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 24
Bio-Rad Labs Acquires QuantaLife For US$162 Million 25
Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For US$3.4 Million 26
Bio-Rad Laboratories Inc – Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Bio-Rad Laboratories Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Bio-Rad Laboratories Inc, Medical Devices Deals, 2010 to YTD 2016 9
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
GnuBio Raises US$10 Million In Series B Financing 12
GnuBio Secures US$5 Million In Second Closing Of Series A Financing 12
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 13
AbD Serotec Enters Into Licensing Agreement With Proteomika 13
Genetic Analysis Enters into Agreement with Bio-Rad Labs 14
Bio-Rad Laboratories Enters into Partnership with Illumina 15
AbD Serotec Enters Into Research Agreement With Dana-Farber Cancer Institute 16
Layerlab Enters Into Co-Marketing Agreement With Bio Rad Labs 16
Vegenics Enters into Licensing Agreement with Bio-Rad Labs 17
AbD Serotec Amends Licensing Agreement With Merck 18
Serotec Enters Into Licensing Agreement With ICR 19
AbD Serotec Enters Into Licensing Agreement With VU University Medical Center 19
GnuBIO Enters Into Licensing Agreement For Microfluidics And Emulsion Based Methodologies 20
AbD Serotec Enters Into An Agreement With UCL Business 21
Bio-Rad Labs Completes Public Offering Of Senior Notes Due 2020 For US$425 Million 22
Bio-Rad Labs Acquires GnuBio, DNA Sequencing Technology Company 23
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 24
Bio-Rad Labs Acquires QuantaLife For US$162 Million 25
Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For US$3.4 Million 26
Bio-Rad Laboratories Inc, Key Competitors 27
Bio-Rad Laboratories Inc, Key Employees 28
Bio-Rad Laboratories Inc, Other Locations 29
Bio-Rad Laboratories Inc, Subsidiaries 30

List of Figures
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Bio-Rad Laboratories Inc, Medical Devices Deals, 2010 to YTD 2016 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Bio-Rad Laboratories Inc (BIO):企業のM&A・提携動向(医療分野)(Bio-Rad Laboratories Inc (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆